Ratings by BofA Securities (Alec W. Stranahan)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/14/2026 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2026 | Beam Therapeutics Inc | BEAM | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 5/8/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2026 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 4/21/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/13/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2026 | Beam Therapeutics Inc | BEAM | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2026 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | CG Oncology | CGON | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | Beam Therapeutics Inc | BEAM | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2026 | Agios Pharma | AGIO | Maintain | Buy (N/A) |
|
Details |
